Skip to main content
. 2012 Nov 2;7:45. doi: 10.1186/1747-597X-7-45

Table 1.

Group demographics

  Buprenorphine (n = 52) Methadone (n = 52) Group comparisonsa
Age (M ± SD)
31 ± 7
35 ± 8
BN < M, p = .007**
Sex, female/male
18/34
20/32
p =.84
35%/65%
38%/62%
 
Verbal intelligenceb (M ± SD)
100 ± 10
101 ± 10
p =.44
Education, patients with primary education/any secondary education
35/17
34/18
p =1.00
67%/33%
65%/35%
 
Substance abuse onset age, years (M ± SD)
16 ± 3
15 ± 2
p = .17
Patients with early onset of substance abusec
15
23
p =.31
29%
44%
 
Duration of OST, months (M ± SD)
14 ± 7
17 ± 10
p = .08
Patients with more than 12 month in OST
30
33
p = .69
57%
63%
 
Number of cognitive testing
 
 
 
patients with one testing
34 (65%)
40 (77%)
p =.28
patients with two or three testing
18 (35%)
12 (23%)
 
Patients with high-frequency substance abuse in the previous monthd
18
22
p =.55
35%
42%
 
Patients with positive drug screen at test
13
13
p = 1.00
25%
25%
 
Patients with the past month daily nicotine use 52
51%
p =.50
100% 98%  

Note. BN = buprenorphine patients, M = methadone patients.

aTested with t-test or Fisher’s Exact Test.

bEstimation based on the vocabulary subtest of the Wechsler Adult Intelligence Scale – Revised (WAIS-R) [30].

cConsidered as early up to 14 years of age.

dConsidered as high when three or more days a week. Alcohol use was taken into account if it was at least mean weekly 16 portions (12 g) for females and 24 portions for males or binge drinking occurred on any day.

**p < 0.01.